Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
- May 17, 2017
May 16, 2017
May 10, 2017Astellas Announces Decision to Discontinue ASP8273 Treatment Arm and Close Randomization for Clinical Study Protocol 8273-CL-0302- Decision follows recommendation of Independent Data Monitoring Committee -
- Apr 27, 2017Astellas Americas President Jim Robinson to discuss the importance of listening to patients in tackling health decision-making, financial burden and transparency in care